Hair Loss in Women: Causes, Types, and Treatment Options

Hair Loss in Women: A Different Experience

Hair loss is often thought of as a men's issue — but roughly 40% of women experience noticeable hair loss by age 50, and many begin losing hair in their 20s or 30s. The psychological impact on women is often greater than in men, given the strong cultural association between hair and femininity. Yet hair loss in women remains significantly underdiagnosed and undertreated, largely because its patterns and causes differ from men's hair loss, and because many women are told their concerns are "just stress" or "normal aging."

This guide covers the primary types of hair loss in women, the underlying causes (including hormonal drivers), and the evidence-based treatment options available in 2025.

Types of Female Hair Loss

Female Pattern Hair Loss (FPHL / Androgenetic Alopecia)

Female pattern hair loss is the most common type, affecting an estimated 30–50% of women during their lifetime. Unlike male pattern baldness — which typically begins at the hairline and crown — FPHL usually presents as diffuse thinning over the top and crown of the scalp, with the hairline often preserved. Grading is done using the Ludwig scale (I–III).

FPHL is driven by genetic sensitivity of hair follicles to dihydrotestosterone (DHT), a metabolite of testosterone. Estrogen normally counterbalances DHT's effects, which is why FPHL often worsens significantly at menopause when estrogen declines.

Telogen Effluvium

Telogen effluvium (TE) is diffuse, widespread hair shedding caused by a disruption to the hair growth cycle — typically a physiological "shock" that pushes large numbers of follicles into the resting (telogen) phase simultaneously. Common triggers include:

• Childbirth (postpartum hair loss typically peaks 3–4 months after delivery)
• Major surgery or illness
• Significant weight loss or crash dieting
• Thyroid disorders
• Iron deficiency or anemia
• Severe psychological stress
• Stopping certain medications (including oral contraceptives)

Telogen effluvium usually resolves once the underlying trigger is identified and addressed. Hair regrowth typically begins within 3–6 months of addressing the root cause.

Alopecia Areata

Alopecia areata is an autoimmune condition in which the immune system attacks hair follicles, causing patchy, often circular areas of hair loss. It can affect the scalp, eyebrows, eyelashes, or any body hair. Severe forms include alopecia totalis (complete scalp hair loss) and alopecia universalis (loss of all body hair). JAK inhibitors (baricitinib, ritlecitinib) are FDA-approved for alopecia areata and represent a major treatment advance in recent years.

Traction Alopecia

Caused by prolonged mechanical tension on the hair follicle from tight hairstyles (braids, weaves, tight ponytails). Most common at the hairline and temples. If caught early, regrowth is possible with style changes; chronic cases may cause permanent follicle damage that cannot be reversed.

Cicatricial (Scarring) Alopecia

Inflammatory conditions that destroy hair follicles and replace them with scar tissue, causing permanent hair loss. Examples include lichen planopilaris and frontal fibrosing alopecia. Early treatment to halt progression is essential, as lost follicles cannot regenerate.

Hormonal Causes of Hair Loss in Women

Hormones play a significant role in female hair loss. Key hormonal contributors include:

• Androgens (testosterone, DHT): Drive FPHL in genetically susceptible women; elevated androgens in PCOS accelerate hair loss
• Estrogen and progesterone: Both protect hair follicles; their decline at menopause often triggers or worsens FPHL
• Thyroid hormones: Both hypothyroidism and hyperthyroidism cause diffuse hair shedding
• Prolactin: Elevated prolactin (from pituitary tumors or medications) suppresses estrogen and can cause hair loss
• Cortisol: Chronic stress and elevated cortisol contribute to telogen effluvium and may worsen FPHL
• Insulin: Insulin resistance (common in PCOS) increases androgens and drives hair follicle miniaturization

Treatment Options for Women

Minoxidil

Minoxidil is the only FDA-approved topical treatment for female pattern hair loss. It prolongs the anagen (growth) phase and increases hair follicle size. The 2% topical solution is FDA-approved for women; the 5% foam is also used but not specifically FDA-approved for women. Oral minoxidil at low doses (0.25–1.25 mg/day) is increasingly used off-label with good results and often fewer scalp side effects than topical forms. Consistent daily use is required for sustained benefit.

Spironolactone

An androgen-blocking medication widely used off-label for FPHL in women with elevated androgen levels or androgen sensitivity. Particularly effective for women with PCOS-related hair loss or documented hyperandrogenism. Not recommended in women trying to conceive. May take 6–12 months to see full effects on hair density.

Finasteride and Dutasteride

5-alpha reductase inhibitors that block DHT production. More commonly used in men, but licensed providers may prescribe for postmenopausal women with FPHL, particularly when spironolactone hasn't been sufficient. Not safe during pregnancy and requires reliable contraception in premenopausal women.

Hormone Replacement Therapy (HRT)

For menopausal women, HRT may help stabilize or reverse hair loss by restoring estrogen's protective effects on follicles. The type of progestogen matters — micronized progesterone is generally preferred over progestins with androgenic activity for women concerned about hair loss. See our guide on hormone therapy for women for a full overview of options.

Platelet-Rich Plasma (PRP)

PRP therapy involves injecting concentrated growth factors from the patient's own blood into the scalp. Evidence suggests it can increase hair density and diameter in FPHL and alopecia areata. Typically requires 3 initial sessions followed by maintenance every 6–12 months. Well-tolerated with minimal downtime.

Low-Level Laser Therapy (LLLT)

FDA-cleared devices (helmets, caps, combs) use low-level laser light to stimulate hair follicle activity. Evidence supports modest efficacy for FPHL with consistent use several times per week. Most effective as an adjunct to other treatments rather than a standalone therapy.

Nutritional Optimization

Iron deficiency is a major, frequently overlooked cause of hair loss in women. Ferritin levels below 30–40 ng/mL are associated with hair shedding even in the absence of frank anemia. Vitamin D, zinc, and biotin deficiencies can also contribute. A comprehensive blood panel is essential before supplementing, as indiscriminate supplementation without confirmed deficiency is unnecessary and occasionally counterproductive.

Getting a Proper Evaluation

Because hair loss in women has many possible causes, an effective evaluation includes a detailed medical history, medication review, and labs that typically include: ferritin, CBC, thyroid panel (TSH, free T3, free T4), comprehensive metabolic panel, total and free testosterone, DHEA-S, prolactin, and vitamin D.

Our providers at Truventa Medical Hair Loss can work through your hair loss history, order appropriate labs, and build a personalized treatment plan. Learn about the best hair loss treatments for women in our related article.

What to Expect from Treatment

Hair loss treatment requires patience. Most treatments take 3–6 months to show initial improvement and 12 months to demonstrate full effect. Hair that has recently miniaturized may recover; follicles that have been dormant for many years may not. Setting realistic expectations while committing to consistent treatment is key to success. Regular follow-up with your provider allows for protocol adjustments based on your response.

Summary

Hair loss in women is common, often hormonal, and increasingly treatable. Understanding which type you have — FPHL, telogen effluvium, alopecia areata, or another pattern — is the essential first step. With the right diagnosis and personalized treatment plan combining topical, oral, and lifestyle interventions, most women can significantly slow or reverse hair loss and improve hair density and quality over time.